Prognostic Relevance of CD200/Btla Deletions in Pediatric Precursor-B Cell Acute Lymphoblastic Leukemia Treated According to the EORTC-CLG 58951 Protocol

被引:0
|
作者
Ghazavi, Farzaneh [1 ]
Lammens, Tim [1 ]
Clappier, Emmanuelle [2 ,3 ]
Suciu, Stefan [4 ]
Caye, Aurelie [2 ,3 ]
Zegrari, Samira [3 ]
Bakkus, Marleen [5 ]
Grardel, Nathalie [6 ]
Benoit, Yves [1 ]
Bertrand, Yves [7 ]
Minckes, Odile [8 ]
Costa, Vitor [9 ]
Ferster, Alina [10 ]
Mazingue, Francoise [11 ]
Plat, Genevieve [12 ]
Plouvier, Emmanuel [13 ]
Poiree, Marilyne [14 ]
Uyttebroeck, Anne [15 ]
Ten Bosch, Jutte Van der Werff [5 ]
Helsmoortel, Hetty [1 ]
Meul, Magali [1 ]
Van Roy, Nadine [1 ]
Philippe, Jan [16 ]
Speleman, Frank [1 ]
Cave, Helsne [2 ,3 ]
Van Vlierberghe, Pieter [1 ]
De Moerloose, Barbara [1 ]
机构
[1] Ghent Univ Hosp, Ghent, Belgium
[2] Univ Paris Diderot, Paris, France
[3] Hop Robert Debre, APHP, F-75019 Paris, France
[4] EORTC Headquarters, Brussels, Belgium
[5] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Brussels, Belgium
[6] INSERM U837, Lille, France
[7] Hosp Civils Lyon, Lyon, France
[8] CHRU, Caen, France
[9] Portuguese Oncol Inst, Oporto, Portugal
[10] HUDERF, Brussels, Belgium
[11] Hop A Calmette, CHR, Lille, France
[12] Childrens Hosp, Toulouse, France
[13] CHRU, Besancon, France
[14] Hop Archet, Nice, France
[15] Univ Hosp Gasthuisberg, Leuven, Belgium
[16] Univ Ghent, B-9000 Ghent, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Is CDKN2A +/-CDKN2B and MTAP inactivation of prognostic significance in B-precursor childhood acute lymphoblastic leukemia? -: Results of EORTC studies 58881 and 58951
    Mirebeau, D
    Acquaviva, C
    Suciu, S
    Bertin, R
    Robert, A
    Boutard, P
    Méchinaud, F
    Plouvier, E
    Otten, J
    Vilmer, E
    Cavé, H
    BLOOD, 2004, 104 (11) : 306A - 306A
  • [22] Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials
    C Piette
    S Suciu
    E Clappier
    Y Bertrand
    S Drunat
    S Girard
    K Yakouben
    G Plat
    N Dastugue
    F Mazingue
    N Grardel
    N van Roy
    A Uyttebroeck
    V Costa
    O Minckes
    N Sirvent
    P Simon
    P Lutz
    A Ferster
    C Pluchart
    M Poirée
    C Freycon
    M-F Dresse
    F Millot
    C Chantrain
    J van der Werff ten Bosch
    K Norga
    C Gilotay
    P-S Rohrlich
    Y Benoit
    H Cavé
    Leukemia, 2018, 32 : 244 - 248
  • [23] Prognostic significance of IKZF1 deletions and IKZF1plus profile in children with B-cell precursor acute lymphoblastic leukemia treated according to the ALL-IC BFM 2009 protocol
    Braun, Marcin
    Pastorczak, Agata
    Sedek, Lukasz
    Taha, Joanna
    Madzio, Joanna
    Jatczak-Pawlik, Izabela
    Wypyszczak, Kamila
    Matysiak, Michal
    Derwich, Katarzyna
    Lejman, Monika
    Kazanowska, Bernarda
    Szczepanski, Tomasz
    Kowalczyk, Jerzy R.
    Mlynarski, Wojciech
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (03) : 430 - 441
  • [24] RELEVANCE OF CD20 EXPRESSION AMONG PEDIATRIC PRECURSOR B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
    Bommannan, Karthik
    Arumugam, Jhansi
    Radhakrishnan, Venkatraman
    Sundersingh, Shirley
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S24 - S24
  • [25] Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia
    Kato, Jason
    Satake, Noriko
    O'Donnell, Robert T.
    Abuhay, Mastewal
    Lewis, Carly
    Tuscano, Joseph M.
    LEUKEMIA RESEARCH, 2013, 37 (01) : 83 - 88
  • [26] BREAKPOINTS OF BTG1 DELETIONS IN PEDIATRIC PRECURSOR-B ACUTE LYMPHOBLASTIC LEUKEMIA CLUSTER TIGHTLY AND GIVE RISE TO A TRUNCATED BTG1 PROTEIN
    Waanders, Esme
    Van Reijmersdal, Simon
    Van der Meer, Laurens T.
    Van Emst, Liesbeth
    Verwiel, Eugene
    Scheijen, Blanca
    Sonneveld, Edwin
    Hoogebrugge, Peter M.
    van Kessel, Ad Geurts
    Van Leeuwen, Frank N.
    Kuiper, Roland P.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 833 - 833
  • [27] Hepatotoxicty in Standard Risk B-Cell Precursor Pediatric Acute Lymphoblastic Leukemia Patients Treated On Pediatric Oncology Group (POG) Protocol 9605
    Chen, Lingling
    Bell, Beverly
    Waller, Jennifer
    Hall, Patricia
    Devidas, Meenakshi
    Lukacik, Marek
    Camitta, Bruce
    BLOOD, 2009, 114 (22) : 802 - 803
  • [28] Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia
    Jeha, Sima
    Behm, Frederick
    Pei, Deqing
    Sandlund, John T.
    Ribeiro, Raul C.
    Razzouk, Bassem I.
    Rubnitz, Jeffrey E.
    Hijiya, Nobuko
    Howard, Scott C.
    Cheng, Cheng
    Pui, Ching-Hon
    BLOOD, 2006, 108 (10) : 3302 - 3304
  • [29] Prognostic significance of CD20 expression in adult B-cell precursor acute lymphoblastic leukemia
    Maury, Sebastien
    Huguet, Francoise
    Pigneux, Arnaud
    Raffoux, Emmanuel
    Thomas, Xavier
    Beldjord, Kheira
    Delabesse, Eric
    Chevallier, Patrice
    Buzyn, Agnes
    Delannoy, Andre
    Chalandon, Yves
    Vernant, Jean-Paul
    Rousselot, Philippe
    Lafage-Pochitaloff, Marina
    Chassevent, Agnes
    Lheritier, Veronique
    Macintyre, Elizabeth
    Ifrah, Norbert
    Dombret, Herve
    Bene, Marie-Christine
    BLOOD, 2007, 110 (11) : 832A - 833A
  • [30] CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia
    Naithani, Rahul
    Asim, Muhammad
    Abdelhaleem, Mohammad
    Punnett, Angela
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09): : E31 - E32